Quick Takeaways
- MILLENNIUM MANAGEMENT LLC filed SCHEDULE 13G for Zentalis Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (ZNTL).
- Disclosed ownership: 5.3%.
- Date of event: 29 Jan 2025.
MILLENNIUM MANAGEMENT LLC - 29 Jan 2025 SCHEDULE 13G Report for Zentalis Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (ZNTL)
- Filing Manager
- MILLENNIUM MANAGEMENT LLC
- Reporting Manager
- Millennium Management LLC
- Symbol
- ZNTL
- Shares outstanding
- 71,345,245 shares
- Disclosed Ownership
- 3,781,298 shares
- Ownership
- 5.3%
- Form type
- SCHEDULE 13G
- Filing time
- 04 Feb 2025, 16:06:32 UTC
- Date of event
- 29 Jan 2025
- Next filing
- 14 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MILLENNIUM MANAGEMENT LLC disclosed 5.3% ownership in Zentalis Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (ZNTL) on 29 Jan 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 04 Feb 2025, 16:06.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Millennium Management LLC | 5.3% | 3,781,298 | 0 | 3,781,298 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 5.3% | 3,781,298 | 0 | 3,781,298 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 5.3% | 3,781,298 | 0 | 3,781,298 | /s/ Israel A. Englander | Israel A. Englander |